Trial Profile
A phase II study of preoperative concurrent chemoradiotherapy with TS-1/ Oxaliplatin in patients with locally advanced rectal cancer(PerSeUS-RC01)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary) ; Antineoplastics; Fluorouracil
- Indications Adenocarcinoma; Carcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms PerSeUS-RC01
- 01 Dec 2021 Results published in the Anticancer Research
- 11 Jun 2020 Status changed from suspended to completed.
- 29 Sep 2013 New trial record